Tempest Therapeutics, Inc. Net Rentable Area
Tempest Therapeutics, Inc. (TPST) had Net Rentable Area of 6.00 thousand item as of 2012-05-01, per its 10-Q filed 2012-11-13.
Discontinued › Notes
us-gaap:NetRentableArea · last filed 2013-02-25
- 2012-05-01: Net Rentable Area 6.00K item.
item
| Period end | Net Rentable Area |
|---|---|
| 2012-05-01 | 6.00K item 10-Q · filed 2012-11-13 |
sqft
| Period end | Net Rentable Area |
|---|---|
| 2012-05-01 | 6.00K sqft 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |